Severity
Moderate
FDA Devices recall · Reported January 19, 2022
Due to dose discrepancy when delivering a plan to a patient in a Non-HFS (Head First Supine) orientation specifically in Feet First Supine (FFS).
Reflexion Medical, Inc. recalled RefleXion Medical Radiotherapy System - System Label: "*** refleXion REF RXM1000 ***"… - a moderate-severity action.
RefleXion Medical Radiotherapy System - System Label: "*** refleXion REF RXM1000 ***"… was recalled by Reflexion Medical, Inc. in January 19, 2022. Reason: Due to dose discrepancy when delivering a plan to a patient in a Non-HFS (Head First Supine) orientation spec…. Check the official notice for the remedy. Verify recall #Z-0470-2022 with the FDA Devices before acting.
The recall
Reflexion Medical, Inc. issued this moderate-severity FDA Devices recall-Due to dose discrepancy when delivering a plan to a patient in a Non-HFS (Head First Supine) orientation spec….
Sourced from official FDA Devices enforcement records. Verify recall #Z-0470-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-0470-2022) was formally reported on January 19, 2022, with the manufacturer initiating the action on November 24, 2021. It is classified under Moderate severity (Class II), with a current status of Terminated. Reflexion Medical, Inc. is listed as the recalling firm, operating out of Hayward, CA. Federal records list the affected scope as 3 devices.
The documented reason for this recall is: Due to dose discrepancy when delivering a plan to a patient in a Non-HFS (Head First Supine) orientation specifically in Feet First Supine (FFS). Distribution data in the federal record shows the product reached: U.S. Nationwide distribution in the states of CA and TX. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,861 medical devices recalls on record
Of 88,001 recalls with an agency hazard classification, 19,020 are high severity, 64,468 moderate, and 4,513 low. A further 16,157 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Moderate
Affected scope
3 devices
Related Recalls
6
6 from same agency
RefleXion Medical Radiotherapy System - System Label: "*** refleXion REF RXM1000 ***" Physics Guide/Treatment Delivery User Manual/Treatment Planning User Manual: "RefleXion X1 Model: RXM1000"
Due to dose discrepancy when delivering a plan to a patient in a Non-HFS (Head First Supine) orientation specifically in Feet First Supine (FFS).
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Moderate (Class II) |
| Status | Terminated |
| Recall number | Z-0470-2022 |
| Date reported | January 19, 2022 |
| Date initiated | November 24, 2021 |
| Recalling firm | Reflexion Medical, Inc. |
| Firm location | Hayward, CA |
| Affected scope | 3 devices |
| Distribution | U.S. Nationwide distribution in the states of CA and TX |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Boston Scientific Corporation · 2026-07-29
Boston Scientific Corporation · 2026-07-29
AVID Medical, Inc. · 2026-07-29
Penumbra, Inc. · 2026-07-29
Alphatec Spine, Inc. · 2026-07-29
Compare this recall with FARADRIVE STEERABLE SHEATH CLEAR, used to facilitate access… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported January 19, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.